Biopterin cofactor and monoamine-synthesizing monooxygenases

Neurochemistry International
T Nagatsu

Abstract

The activities of three pterin-requiring monooxygenases, phenylalanine hydroxylase, tyrosine hydroxylase and tryptophan hydroxylase, are regulated by the level of the pterin cofactor, (6R)- l -erythro- tetrahydrobiopterin , which is synthesized from guanosine triphosphate (GTP). Since tyrosine hydroxylase or tryptophan hydroxylase is the rate-limiting enzyme for the biosynthesis of catecholamines (dopamine, norepinephrine and epinephrine) or serotonin in monoaminergic neurons, biosynthesis of tetrahydrobiopterin from GTP may also regulate the tissue level of monoamine transmitters. Recent evidences indicate that biosynthesis of tetrahydrobiopterin and that of biogenic monoamines may be regulated each other.

References

Nov 1, 1975·Biochemical Pharmacology·Y NumataS Matsuura
Jan 1, 1976·Life Sciences·D H Park, M Goldstein
Jan 11, 1977·Biochimica Et Biophysica Acta·Y NumataS Matsuura
Mar 1, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·T NagatsuM Sano
Mar 14, 1978·Biochimica Et Biophysica Acta·T NagatsuM Akino
Mar 1, 1978·Annals of Neurology·I J ButlerS Kaufman
May 30, 1978·Biochemical and Biophysical Research Communications·T Yamauchi, H Fujisawa
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·T H JohD J Reis
May 1, 1979·Journal of Neurochemistry·R A LevineW Lovenberg
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·W LovenbergI Hanbauer
Apr 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·H C CurtiusH Schmidt
Sep 28, 1978·The New England Journal of Medicine·S KaufmanS Pueschel
Oct 1, 1975·Journal of Neurochemistry·M B YoudimS Bourgoin
Oct 16, 1975·The New England Journal of Medicine·S KaufmanA Krumholz
Oct 24, 1975·Brain Research·M J BrownsteinJ S Kizer
Jul 12, 1974·Science·R J WurtmanJ D Fernstrom
Jul 15, 1972·Biochemical Pharmacology·T NagatsuT Sugimoto
Oct 8, 1974·Biochemical and Biophysical Research Communications·T NukiwaA Ichiyama
Sep 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·J M MusacchioC A McQueen
Nov 1, 1967·Analytical Biochemistry·G GuroffA Abramowitz
May 1, 1969·Biochemical Pharmacology·E JequierA Sjoerdsma
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·P R VullietN Weiner
Mar 14, 1980·Biochimica Et Biophysica Acta·T KatoS Matsuura
Feb 5, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·T NagatsuH Narabayashi
May 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M M Abou-Donia, O H Viveros
May 29, 1981·Biochemical and Biophysical Research Communications·T Yamauchi, H Fujisawa
Sep 15, 1981·Biochimica Et Biophysica Acta·K OkaT Nagatsu
Feb 1, 1982·European Journal of Biochemistry·S Okuno, H Fujisawa
Dec 1, 1981·Journal of Neurochemistry·A J Mandell, P V Russo
Aug 1, 1980·Journal of Neurology, Neurosurgery, and Psychiatry·A C WilliamsD B Calne
Mar 15, 1982·Biochemical and Biophysical Research Communications·S KatohS Yamada
Feb 1, 1982·European Journal of Biochemistry·H Nakata, H Fujisawa

❮ Previous
Next ❯

Citations

Jan 1, 1990·Journal of Neural Transmission. General Section·Y HirataT Nagatsu
Jan 1, 1988·The International Journal of Biochemistry·M Sawada, T Nagatsu
Jan 1, 1986·Neurochemistry International·A TogariT Nagatsu
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·S N Young, A M Ghadirian
Feb 19, 2002·Expert Opinion on Biological Therapy·Hoang N Le, David M Frim
Jan 5, 2001·Expert Opinion on Investigational Drugs·D M Frim, U J Kang
Jun 3, 2008·Journal of Neurochemistry·Sarah L GordonPhillip W Dickson
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Tomas Bjorklund, Jeffrey H Kordower
Mar 4, 2009·Biochimica Et Biophysica Acta·Tomas Björklund, Deniz Kirik
Sep 1, 1984·Analytical Biochemistry·T NagatsuH Ogawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.